Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Total monthly reach
Estimated from 7 chart positions in 7 markets.
By chart position
- 🇺🇸US · Life Sciences#1075K to 30K
- 🇪🇸ES · Life Sciences#1511K to 10K
- 🇯🇵JP · Life Sciences#1731K to 10K
- 🇮🇩ID · Life Sciences#2710K to 30K
- 🇵🇹PT · Life Sciences#703K to 10K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
11K to 48K🎙 ~2x weekly·50 episodes·Last published 2w ago - Monthly Reach
Unique listeners across all episodes (30 days)
21K to 96K🇺🇸31%🇮🇩31%🇪🇸10%+4 more - Active Followers
Loyal subscribers who consistently listen
8.4K to 38K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
Episode: 50 - Ramona Burress and Cassandra O’Neal on Health Equity That Works
May 5, 2026
39m 49s
Episode: 49 - Mike Sullivan on AI and Clinical Operations in the Year 2030
Apr 7, 2026
32m 24s
Episode: 48 - Florence Mowlem on the Challenges and Solutions of Pediatric Rare Disease Trials
Mar 10, 2026
22m 54s
Episode: 47 - Joseph Kim on Pragmatic Solutions to Age-Old Problems
Feb 3, 2026
25m 01s
Episode: 46 - Dan Drozd on How Noninterventional Studies Can Change the Clinical Research Game
Jan 6, 2026
25m 31s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 5/5/26 |  Episode: 50 - Ramona Burress and Cassandra O’Neal on Health Equity That Works | Health equity is being reorganized, renamed, or quietly deprioritized. Ramona Burress, co-founder of Onyx Health Collective, and Cassandra O’Neal, founder of Illuminated Arc Consulting, join the Scope of Things podcast for a direct, practical conversation about health equity in clinical trials. They break down what “decision-grade intelligence” looks like for site selection and community integration, why marketing-style segmentation and better storytelling can improve outreach, and why health... | 39m 49s | ||||||
| 4/7/26 |  Episode: 49 - Mike Sullivan on AI and Clinical Operations in the Year 2030 | What will AI and clinical trials look like in the year 2030? Mike Sullivan, head of IT globally for development operations at Bristol Myers Squibb, joins The Scope of Things to discuss how creating value with AI depends on redesigning how clinical operations teams work. He covers the four pillars of what AI and clinical operations can look like in the next few years, as well as how AI will affect the job market. Plus, host Deborah Borfitz gives you the latest rundown on building the capacity ... | 32m 24s | ||||||
| 3/10/26 |  Episode: 48 - Florence Mowlem on the Challenges and Solutions of Pediatric Rare Disease Trials | How can electronic capture of clinical outcome assessments (eCOA) help with the unique challenges of pediatric rare disease trials? Florence Mowlem, chief scientific officer of uMotif, joins The Scope of Things to offer her expertise on eCOA, share advice for companies on vetting technology providers, and discuss where sponsors are tripping up when it comes to pediatric rare disease trials. Plus, host Deborah Borfitz brings you the latest news on a possible probiotic for preventing immune sys... | 22m 54s | ||||||
| 2/3/26 |  Episode: 47 - Joseph Kim on Pragmatic Solutions to Age-Old Problems | Joining this month’s episode of The Scope of Things is Joseph Kim, chief strategy officer of ProofPilot, who talks about his company’s first-ever CORE Symposium, where pharma pros shared practical solutions to age-old trial challenges. Kim provides a pragmatic viewpoint on the problematic trio of clinical trials—study execution, recruitment, and engagement—and what change agents are needed to pave the way forward and find an exit from the bottlenecks. Plus, host Deborah Borfitz delivers the l... | 25m 01s | ||||||
| 1/6/26 | Episode: 46 - Dan Drozd on How Noninterventional Studies Can Change the Clinical Research Game | Noninterventional studies in clinical research are underutilized in clinical research and inefficient. Dan Drozd, CMO of PicnicHealth, knows we can do better. With host Deborah Borfitz, Drozd discusses the issues and ramifications researchers face from the lack of noninterventional studies, offers tactics for raising the bar for evidence generation, and shares what he expects in the clinical research space in 2026 in this episode of the Scope of Things. Plus, Borfitz shares the latest news on... | 25m 31s | ||||||
| 12/2/25 |  Episode: 45 - Doug Bain on Streamlining Clinical Trials | Doug Bain, founder and consulting partner of ClinFlo, discusses his proposed regulatory blueprint for digital trials in the latest episode of The Scope of Things podcast. With host Deborah Borfitz, Bain delves into his strategy for turning 21 CFR Part 11 into a more practical regulation that streamlines rather than bogs down clinical trials, what would qualify someone to take on the role as a trusted third party (and what makes them trustworthy), and the new FDA administration’s modernization... | 23m 42s | ||||||
| 11/4/25 |  Episode 44 - SCOPE Europe 2025 on AI Literacy Training, Reducing Excess Data Collection, Combating Superbugs | This episode of the Scope of Things features an exclusive panel at SCOPE Europe 2025 covering regulatory requirements for AI literacy training, featuring industry executives Jonathan Crowther, head of the operational design center at Merck KGaA; Janie Hansen, global development information management, business systems transformation at Daiichi Sankyo; Francis Kendall, head of statistical programming, digital and data sciences at Biogen; and James Weatherall, vice president and chief data scie... | 16m 19s | ||||||
| 10/7/25 |  Episode: 43 - Overcoming the Deadlock in Patient Recruitment With Christine Senn | For decades, clinical trial recruitment has been the biggest challenge in the industry. Christine Senn, senior vice president of Site-Sponsor Innovation at Advarra, offers insights into why the struggle continues, such as delays in getting regulations updated after a quarter of a century, and how to overcome the deadlock in clinical trial recruitment that is tied to current obsolete marketing guidelines. Also, host Deborah Borfitz shares the latest on beta blockers, low dose aspirin lowering ... | 24m 17s | ||||||
| 9/9/25 |  Episode: 42 - Myeloma Research on a Global Scale with Joseph Mikhael | Joseph Mikhael, chief medical officer of The International Myeloma Foundation, and his organization are pulling all the stops to find a true cure for multiple myeloma, a rare and often fatal blood cancer. He shares the origins and mission of the Black Swan Research Initiative, a research project dedicated to preventing myeloma and finding a cure, and how global collaborators are contributing to multiple myeloma research. Also, host Deborah Borfitz delivers the latest news on ChatGPT determini... | 28m 18s | ||||||
| 8/5/25 | Episode: 41 - How Non-Profits Are Filling Unique Roles in Clinical Research | Children’s Tumor Foundation CEO Annette Bakker discusses what non-profit organizations uniquely bring to clinical research and new financial models sustaining their contribution. Plus, host Deborah Borfitz rounds up the latest news in clinical research: new funding approaches for ALS clinical trials, spatial biology to match patients to trials, a bio map of lung cancer tumor changes, improving diabetes treatment outcomes for patients in China, and more. Show Notes News Roundup&nb... | 35m 13s | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 7/8/25 |  Episode 40: The Advancement and Implementation of Pragmatic Trials | The latest on a trio of pragmatic trials for lung cancer treatment, the implementation of national-scale pharmacogenomic testing, an efficient approach to comparing commonly used intravenous fluids, improving access to gene therapy trials for a progressive heart condition, the landscape for Alzheimer’s disease studies, clinical trials that predict the most effective therapy, and the creation of AI agents for clinical research. Joining the discussion is Bethany Kwan, director of the Disseminat... | 27m 49s | ||||||
| 6/3/25 |  Episode: 39 - Blythe Adamson on Patient-Level Real-World Data for Multinational Oncology Research | In this episode of the Scope of Things, host Deborah Borfitz brings you the latest news on AI-recommended precision dosing, organoid drug testing aiding treatment selection for bowel cancer, an AI tool for stratifying lung cancer patients, using HIV drugs to treat Alzheimer’s disease, and the potential value of magic mushrooms to remedy the mood symptoms of Parkinson’s. Blythe Adamson, international head of outcomes research and evidence generation at Flatiron Health, also joins in to discuss... | 26m 17s | ||||||
| 5/6/25 |  Episode: 38 - Tackling the Misinformation Epidemic with Briony | In this episode of the Scope of Things, host Deborah Borfitz brings you the news on a precision medicine initiative in Sweden integrating research with healthcare, newly available cardiometabolic clinical data registries for real world evidence projects, updates to guidelines on the reporting of clinical trials, AI improving the monitoring of movement disorders, and the best-yet biomarker for stroke and dementia risk. Joining the conversation is Briony Swire-Thompson, director of the Psycholo... | 19m 57s | ||||||
| 4/8/25 |  Episode: 37 - Using AI to Translate Clinical Trial Results with Ravi Parikh | In this episode of The Scope of Things, host Deborah Borfitz covers the latest news, including setting expectations for Phase II cancer trials, key learnings about dementia from the Nun Study, links between cardiovascular disease and mild cognitive impairment, using aspirin to prevent cancer spread, a clinical trial map to improve study access, and a naturally occurring molecule that rivals Ozempic in its weight loss potential. Deborah also speaks with Ravi Parikh, medical director of data an... | 25m 15s | ||||||
| 3/4/25 |  Episode: 36 - Wes Michael on Enhancing Patient Voices and Sharing Their Insights | In this episode of the Scope of Things, host Deborah Borfitz delivers the latest on an AI-powered trial screening tool that outperforms research staff, a strategy report on ways to boost cancer vaccine work, the continued absence of pregnant women in clinical trials, a program bringing studies directly to people in rural Utah, and efforts to integrate clinical trials into routine patient care in medically underserved areas of Oklahoma. Wes Michael, founder and president of Rare Patient Voice,... | 27m 40s | ||||||
| 2/14/25 |  Episode: 35 - SCOPE 2025, Participant Engagement Award Winners, How AI is Helping Trials, and More | In this episode of the Scope of Things, host Deborah Borfitz provides the latest on new criteria for defining and diagnosing obesity, the case for including pregnant women in vaccine trials, the subtyping of osteosarcoma, an inert gas being tested as an Alzheimer’s treatment, and more. Joining the conversation is David Sall, president and CEO of Patient Enrollment Advisors, who talks about the origins of the Participant Engagement Award at SCOPE 2025 and how the conversation around participan... | 23m 44s | ||||||
| 1/7/25 |  Episode: 34 - Ringing in 2025 With Validating Novel Digital Clinical Measures, Decentralized Trials, and More | In this episode of the Scope of Things, host Deborah Borfitz delivers the news on an investigation into data reporting problems in major Ticagrelor clinical trial PLATO, the need for more sex-aware cancer research, Alzheimer’s studies looking at brain shrinkage associated with immunotherapies (and repurposing drugs as potential new treatments), and a large, decentralized trial that successfully uncovered disease-causing genetic variants in hundreds of participants. Benjamin Vandendriessche, c... | 27m 13s | ||||||
| 12/10/24 |  Episode:33 - Orr Inbar Discusses Saving Costs and Complications With Clinical Trial Simulations | In this episode of the Scope of Things, host Deborah Borfitz covers concerns surrounding the study and treatment of obesity, a new “opening doors” initiative to clinical trials, debate over the European Union AI Act, the first international-level clinical study using secure multiparty computation, a hopeful treatment for kids with lethal brain tumors, and a ChatGPT tool created by the NIH to match potential volunteers to relevant studies. Joining the conversation is Orr Inbar, CEO and co-foun... | 34m 33s | ||||||
| 11/5/24 |  Episode: 32 - SCOPE Europe 2024, AI, New Cancer Treatments, More | In this episode of the Scope of Things, host Deborah Borfitz shares the latest news on a drug repurposing AI model now being tested in rare disease clinical trials, a new way forward for triple-negative breast cancer, Jill Pellegrino’s transition from CVS to AutoCruitment, incorporating placental pathology into perspective clinical trials, making ethical oversight of clinical trials more “fit-for-purpose,” and publication bias with industry sponsored studies for psychiatric drugs. We also hav... | 18m 35s | ||||||
| 10/1/24 |  Episode: 31 - Aaron Mackey on Trial Planning and How AI Can Help With Diversity | Tune in for the latest news and trends in this month’s episode of the Scope of Things, where host Deborah Borfitz covers everything you need to know about a pending launch of a large treatment trial for Graves’ disease, a recruitment campaign for a diagnostic tampon, Walgreens and BARDA’s new partnership, how eligibility criteria has been excluding people of African or Middle Eastern descent from cancer studies, and more. Joining the discussion is Aaron Mackey, vice president of AI and data s... | 29m 01s | ||||||
| 9/3/24 |  Episode: 30 - Shining the Spotlight on Rare Disease Trials With Uncommon Cures | This month’s episode of The Scope of Things features the latest trending news from host Deborah Borfitz, including a planned library of “nature’s drugs” targeting complex diseases, a paradoxical approach to treating cancer, how government policies can help improve equitable access to cancer trials, and the possibilities of reversing multiple sclerosis nerve damage. Marshall Summar, CEO of Uncommon Cures, and Tamanna Roshan Lal, Chief Medical Officer of Uncommon Cures, join the conversation to... | 25m 52s | ||||||
| 8/6/24 |  Episode 29 - Patient-Focused Drug Design, Enrollment Challenges, and More With Hannah Kemp | Tune into this month’s episode of the Scope of Things, where host Deborah Borfitz covers the use of AI for trial screening and recruitment purposes, a diabetes drug that may help treat sleep apnea, questionable advice from the FDA given to departing staffers, why the entire clinical trial enterprise may need to be revamped to eliminate systemic biases, and more. Hannah Kemp, vice president of strategic client engagement at Surgo Health, also joins the conversation to talk about how Surgo Heal... | 30m 49s | ||||||
| 7/9/24 |  Episode: 28 - Jonathan Kimmelman on Research Ethics and Dilemmas in Clinical Trials | In this month’s episode of the Scope of Things, host Deborah Borfitz gives you the latest news on the fallacy of a survival benefit for cancer patients participating in clinical trials, how and why federally qualified health centers are getting involved in studies, efforts to disrupt the current practice of excluding pregnant and lactating women from participation, great news about the impact of precision medicine on the outcomes of kids suffering from aggressive cancers, and more. Jonathan K... | 36m 29s | ||||||
| 6/4/24 |  Episode: 27 - Yvonne Rodriguez on Making Clinical Trials Accessible for Everyone | In this episode of the Scope of Things, host Deborah Borfitz covers the latest news on an AI model for comparing drug effectiveness, adoption of minimal residual disease as an endpoint for multiple myeloma, using HIV treatments for Alzheimer’s disease, lack of diversity in Alzheimer’s trials, and more. Yvonne Rodriguez, founder and CEO of Egality Sciences, also joins the conversation to talk about breaking down the barriers to clinical research participation in underserved communities. She al... | 25m 14s | ||||||
| 5/7/24 |  Episode: 26 - Digital Twins, Care-For-All European Platform, and the Impact and Future of Wearables and Microsampling | In this episode of the Scope of Things, host Deborah Borfitz brings you the monthly breakdown on current events, such as tailoring medications to individual patients using digital twins, the use of a skin biopsy test to diagnose neurodegenerative diseases, and the launch of a European-wide platform promoting access to care for all. She also speaks with Michael Snyder, chair of the department of genetics at Stanford University School of Medicine and director of the Center of Genomics and Perso... | 33m 37s | ||||||
Showing 25 of 51
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
7 placements across 7 markets.
Chart Positions
7 placements across 7 markets.